Meta-analysis of the effect of sodium-dependent glucose transporter 2 inhibitors on C-reactive protein in type 2 diabetes

6Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: As novel hypoglycemic drugs, the effects of sodium-dependent glucose transporter 2 inhibitors (SGLT-2I) on inflammatory factors such as C-reactive protein (CRP) remain unclear. Methods: We conducted a meta-analysis of studies on SGLT-2I in the treatment of type 2 diabetes (T2DM) to observe the changes of CRP in patients with T2DM. We searched 4 electronic databases (CNKI, PubMed, EMBASE, and Cochrane Library) for articles published up to December 31, 2021. Studies were analyzed using a random-effects model to obtain standard deviation mean differences (SMDs) and 95% confidence intervals (CIs). Sensitivity and subgroup analyses were performed. Publication bias was evaluated using funnel plots and Egger test. Results: We included data from 927 patients in 13 confirmatory trials that showed a significant decrease in CRP among patients with T2DM treated with SGLT-2I. The decrease was more significant with than without SGLT-2I. In subgroup analysis according to nationality, medication, and comorbidities, CRP reduction was associated with nationality, SGLT-2I type, and the presence of comorbidities. Sensitivity analysis showed that our results were reliable and found no evidence of substantial publication bias. Conclusions: SGLT-2I could reduce CRP levels in patients with T2DM. Registration: International Prospective Register for Systematic Reviews (PROSPERO) number CRD42021268079.

References Powered by Scopus

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

3842Citations
N/AReaders
Get full text

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

3656Citations
N/AReaders
Get full text

Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study (IRAS)

2124Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure

6Citations
N/AReaders
Get full text

Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival

5Citations
N/AReaders
Get full text

Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment

4Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sun, W., Xing, Y., Kong, D., Zhang, Z., Ma, H., & Yang, L. (2022, September 23). Meta-analysis of the effect of sodium-dependent glucose transporter 2 inhibitors on C-reactive protein in type 2 diabetes. Medicine (United States). Lippincott Williams and Wilkins. https://doi.org/10.1097/MD.0000000000030553

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 1

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

60%

Pharmacology, Toxicology and Pharmaceut... 2

40%

Save time finding and organizing research with Mendeley

Sign up for free